irsogladine has been researched along with transforming growth factor alpha in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; Hikawa, T; Hori, S; Kuwano, M; Matsuo, K; Mori, T; Wakabayashi, Y; Yamada, Y | 1 |
1 other study(ies) available for irsogladine and transforming growth factor alpha
| Article | Year |
|---|---|
Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor.
Topics: Fibroblast Growth Factor 2; Glioma; Humans; Neoplasm Invasiveness; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; RNA, Messenger; Tissue Plasminogen Activator; Transforming Growth Factor alpha; Triazines; Tumor Cells, Cultured; Up-Regulation; Urokinase-Type Plasminogen Activator | 2000 |